SlideShare a Scribd company logo
Enzymes
Presented By
Dr. Salwa Abo El-khair
3
Catalytic Proteins 4: Enzymes
Enzyme Inhibition
6
 Enzyme inhibition is one way of regulating enzyme
activity .
 Most therapeutic drugs function by inhibition of a
specific enzyme.
 In the body , some of the processes controlled by
enzyme inhibition are blood coagulation, blood clot
dissolution (fibrinolysis) and inflammatory reactions.
Enzyme inhibitors are Reversible or Irreversible
 Enzyme Inhibition means decreasing or cessation
in the enzyme activity.
 The inhibitor is the substance that decreases or
abolishes the rate of enzyme action.
 According to the similarity between the inhibitor
and the substrate, enzyme inhibition is either:
 Competitive inhibition:
 Non-competitive inhibition:
Reversible
Irreversible
I. Competitive inhibition
 There is structural similarity between the
inhibitor and substrate.
 The inhibitor and the substrate compete with
each other to bind to the same catalytic site of the
enzyme.
 The inhibition is reversible.
 It can be relieved by increasing substrate
concentration.
 It does not affect Vmax. It increases Km.
COMPETITIVE INHIBITION
1. Inhibitor compete with substrate
2. Structurally is similar to the substrate
3. Inhibition is reversible
4. Inhibitor does not bind with E-S complex
5. Inhibition is relieved in excess substrate concentration
6. Inhibitor with enzyme forms enzyme inhibitor complex
(E-I)
Competitive Inhibition
presented as:
E + S  E●S  E + P
+
I

E●I
I resembles S
I binds at active site reversibly
E●I cannot bind to S so no reaction
substrate
inhibitor
Molecular interpretation for competitive
inhibition
competitive inhibitor binds to same site as the
substrate (competes).
its structure usually resembles substrate.
While the inhibitor is bound, the enzyme cannot
bind substrate and no reaction possible.
Many pharmaceutical agents are
competitive inhibitors so are many toxic
substances.
No I
Competitive Inhibition
+I
+more I
Vmax
Km
In competitive inhibition, can always
add enough [S] to overcome inhibition.
 same Vmax
Examples and Clinical Use :
19
1- Malonate blocks the action of Succinate dehydrogenase
which catalyzes the transformations of succinate to
fumarate
The formulae of malonic and succinic acids show
the structural similarity between them.
COOH COOH
CH2 CH2
COOH CH2
COOH
Malonic Acid Succinic Acid
21
Succinate and Malonate are 2 structural analogs.
23
2. Sulfonamides : are structural analogs of p-amino
benzoic acid used by bacteria for folic acid synthesis.
• Folic acid is essential for growth and multiplication .
Hence the sulfa drugs as bacteriostatic
24
3. Dicumarol is structurally similar to vitamin K and
can act as anticoagulant by competitive inhibition
of vitamin K activity
Inhibitor
Substrate
Enzymatic process
Malonic acid
Succinic acid
Succinate
dehydrogenase
Sulfanilamide
Para aminobenzoic
acid (PABA)
Folic acid synthesis
in bacteria
Dicumarol
Vitamin K
Prothrombin
synthesis
Acetazolamide
(diamox)
Carbonic acid
Carbonic anhydrase
Allopurinol
(zyloric)
Xanthine
Xanthine oxidase
physostigmine
Acetyl choline
Choline esterase
Enzyme behavior in present of competitive
inhibitor:
 Vmax is unchanged.
 Km is increased, more substrate is needed
to keep the reaction going at ½ Vmax.
Michaelis Menten hyperbolic plot:
 The initial velocity (Vi) of the enzyme
reaction rises more slowly when competitive
inhibitor is present, but eventually reaches
normal Vmax when [S] is very high.
No I
Competitive Inhibition
+I
+more I
Vmax
Km
In competitive inhibition, can always
add enough [S] to overcome inhibition.
 same Vmax
Vmax
Vmax
2
Km Km,app
[Substrate]
Reaction
Rate - Inhibitor
+ Inhibitor
Lineweaver-Burk plot:
 It shows a steeper slope to the line when a
competitive inhibitor is present.
 The series of lines pivot on they intercept,
since Vmax is not changed for competitive
inhibition.
 The X-intercept becomes smaller as Km
increases in competitive inhibition.
1/[S]
1/v
1/Vmax
Competitive inhibition
Double reciprocal plot
Same 1/v intercept,
same Vmax
Different slopes,
competitive
Inhibition changes apparent Km
Note: inhibition line always above no inhibition.
+ more I
+I
No I
Competitive inhibition: Km INCREASED, V-max NO CHANGE
AP Biology 2007-2008
Got any Questions?!
II- Non-competitive inhibition
Non-competitive inhibition may be:
 Specific.
 Non-specific.
Non-specific non-competitive inhibition
As enzymes are proteins in nature, any factor that
causes protein denaturation will inhibit enzyme
activity e.g.
 Strong acids,
 Strong alkalis,
 Severe agitation
 Repeated freezing and thawing.
Specific non-competitive inhibition
 There is no structural similarity between the inhibitor
and the substrate.
 The inhibitor does not bind to the catalytic site as the
substrate but it binds to another site.
 It can bind enzyme or to enzyme substrate complex.
 The inhibition is irreversible. It cannot be relieved by
increasing substrate concentration.
 It decreases Vmax. It does not affect Km.
NON-COMPETITIVE INHIBITION
Not resemble substrate
Binds to site other than active site
Can bind with ES complex
Usually It is irreversible
Increasing substrate concentration not abolish inhibition
Irreversible Noncompetitive inhibitors
Noncompetitive Inhibition
E + S  E●S E + P
+ +
I I
 
E●I  E●S●l inhibitor
substrate
E●I and E●S●I not productive, depletes
E and E●S
Non- Competitive Inhibition
48
 [I] and [S] may combine at different sites of the
enzyme, so formation of both [El] and [EIS]
complexes is possible.
 Since [EIS] may break down to form product at a
slower rate than [ES] complex, the reaction may be
slowed but not stopped. Irreversible non competitive
inhibition decreases Vmax but does not affect Km.
Noncompetitive Inhibition
E + S  E●S E + P
+ +
I I
 
E●I  E●S●l inhibitor
substrate
E●I and E●S●I not productive, depletes
E and E●S
Molecular Interpretation:
Inhibitor binds the enzyme somewhere
different from where the substrate binds.
So the inhibitor does not care whether
substrate is bound or not.
Inhibitor changes the conformation of the
enzyme at the active site so no reaction is
possible with inhibitor bound.
E●I and E●S●I not productive
Non-competitive inhibition may be caused by:
 Inhibition of sulphahydryl group.
 Inhibition of cofactors.
 Inhibition of specific ion activator.
A) Inhibition of Sulphahydryl (-SH) group
 Many enzymes depend on free sulphahydryl
group for its activity.
 Inhibition of this group leads to loss of the
enzyme activity.
Sulphahydryl group can be inhibited by:
1- Oxidizing agents as potassiumferricyanide
2 E-SH E-S-S-E
Potassium Ferricyanide Potassium Ferrocyanide
Where E-SH is an enzyme containing free sulphahydryl
group.
2- Alkylating agents as iodoacetic acid (I-CH2-
COOH) and iodoacetamide
E-SH E-S-CH2-COOH
I-CH2-COOH HI (iodic acid)
3- Effect of heavy metals:
Heavy metal ions as mercury (Hg++) and lead
(Pb++) block sulphahydryl group of enzymes
forming mercaptides.
2 E-SH + Pb++ E-S-Pb-E-S
B) Inhibition of cofactors
The inhibitors block an active group in
coenzymes or the prosthetic group:
1- Coenzyme inhibition: e.g.
hydrazine and hydroxylamine block the aldehyde
group in the pyridoxal phosphate, which is a
coenzyme needed for transmination,
decarboxylation and desulfhydration of amino
acids.
2- Inhibitors of prosthetic group: e.g.
carbon monoxide (CO), cyanide and bisulphate
block the iron in the haem which is the prosthetic
group of cytochrome oxidase enzyme.
C) Inhibition of metal ion activator
 Removal of calcium ions from blood prevents its
coagulation.
 Ca++ is needed to activate thrombokinase enzyme
which converts the inactivate prothrombin to
active thrombin that causes blood clotting.
Enzyme behavior in presence of non-competitive
inhibitor:
 Vmax is decreased.
 Km remains unchanged.
Michaelis Menten hyperbolic plot:
 It shows that the initial velocity (Vi) of the
enzyme reaction rises more slowly when non-
competitive inhibitor is present, and levels off
at reduced Vmax.
.
Vmax
Vmax
2
1
2
1
Vmax,app
Km Km,app
[Substrate]
Reaction
Rate
- Inhibitor
+ Inhibitor
Vmax,app
Lineweaver-Burk plot:
 It shows that the series of lines pivot on the
negative X intercept, since Km is unchanged for
non-competitive inhibition.
 Y-intercept and slope increase due to the
reciprocal dependence on Vmax, which decreases.
No I
+ I
1/[S]
1/v
Noncompetitive
Inhibition
different slopes, different 1/v intercepts.
Non competitive inhibition : Km no change , V-max
decreased
AP Biology 2007-2008
Got any Questions?!
The Effects of Inhibitors on Enzyme Kinetics
The distinction between competitive and non-
competitive enzyme inhibition can be determined
by plotting enzyme activity with and without
the inhibitor present.
Enzyme behavior in present of competitive
inhibitor:
 Vmax is unchanged.
 Km is increased, more substrate is needed
to keep the reaction going at ½ Vmax.
Vmax
Vmax
2
Km Km,app
[Substrate]
Reaction
Rate - Inhibitor
+ Inhibitor
Enzyme behavior in presence of non-competitive
inhibitor:
 Vmax is decreased.
 Km remains unchanged.
.
Vmax
Vmax
2
1
2
1
Vmax,app
Km Km,app
[Substrate]
Reaction
Rate
- Inhibitor
+ Inhibitor
Vmax,app
AP Biology 2007-2008
Don’t be inhibited!
Ask Questions!
Activity
 1- …………… occurs when the inhibitory chemical, which
has no similarity to the substrate, binds to the enzyme other
than at the active site.
(A) Noncompetitive Inhibition
(B) Competitive Inhibition
(C) Un-catalysed reaction
(D) All A, B and C

2- Km values are not altered by which type of inhibitor
a) Competitive inhibitors
b) Non competitive inhibitors
c) Uncompetitive inhibitors
d) All of these
Activity
 1- The inhibition of succinate dehydrogenase by malonate is
an example for
(A) Noncompetitive Inhibition
(B) Competitive Inhibition
(C) Feed back inhibition
(D) None of these
2- The noncompetitive inhibitor
a) Increases Vmax and Km
b) Decreases Vmax
c) Increases Km without affecting Vmax
d) Decreases Km and Vmax
Activity
 Compare between competitive and non competitive
enzyme inhibition.
 Discuss with 3 examples competitive inhibition
 Enumerate 3 methods of noncompetitive inhibition
 Discuss in short the effect of inhibitors on enzyme
kinetics .
Thank you

More Related Content

Similar to enzymes lecture 3 2015 animation.pdf

Enzyme inhibition.ppt
Enzyme inhibition.pptEnzyme inhibition.ppt
Enzyme inhibition.ppt
MusabbirRahman4
 
Enzyme Inhibitors, Activation energy and MEC.
Enzyme Inhibitors, Activation energy and MEC.Enzyme Inhibitors, Activation energy and MEC.
Enzyme Inhibitors, Activation energy and MEC.
pratham4012
 
Basics of Enzyme Catalysis
Basics of Enzyme CatalysisBasics of Enzyme Catalysis
Basics of Enzyme Catalysis
Fahad Ullah
 
Enzyme inhibition
Enzyme inhibitionEnzyme inhibition
Enzyme inhibition
Dipesh Tamrakar
 
Enz inhi 5 lec
Enz inhi 5 lecEnz inhi 5 lec
Enz inhi 5 lec
Geeta Jaiswal
 
Enzyme
Enzyme Enzyme
Enzyme
anhtieng
 
Enzyme unit 4 5
Enzyme unit 4  5Enzyme unit 4  5
Enzymes
EnzymesEnzymes
Enzymology enzyme inhibition &therapeutic uses
Enzymology enzyme inhibition &therapeutic usesEnzymology enzyme inhibition &therapeutic uses
Enzymology enzyme inhibition &therapeutic uses
rohini sane
 
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAYENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
Shikha Popali
 
factors affecting enzyme activity
factors affecting enzyme activityfactors affecting enzyme activity
factors affecting enzyme activity
muti ullah
 
enzyme inhibition.pptx
enzyme inhibition.pptxenzyme inhibition.pptx
enzyme inhibition.pptx
Kashvi Jadia
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
Shikha Popali
 
Regulation of enzymes activity 0a08fd94fd.pdf
Regulation of enzymes activity 0a08fd94fd.pdfRegulation of enzymes activity 0a08fd94fd.pdf
Regulation of enzymes activity 0a08fd94fd.pdf
beherasudarshan187
 
Enzymes 2019
Enzymes 2019Enzymes 2019
Enzymes 2019
Ayman Hany
 
Riversible enzyme inhibitors
Riversible enzyme inhibitorsRiversible enzyme inhibitors
Riversible enzyme inhibitors
Mahendra G S
 
Enzyme Inhibitors
Enzyme InhibitorsEnzyme Inhibitors
Enzyme Inhibitors
Mahendra Mahi
 
Types of enzyme inhibition
Types of enzyme inhibitionTypes of enzyme inhibition
Types of enzyme inhibition
Diksha Gupta
 
Enzyme in-therapy-1-1
Enzyme in-therapy-1-1Enzyme in-therapy-1-1
Enzyme in-therapy-1-1
Rana Ahmed
 
Enzyme inhibition AND ITS TYPES
Enzyme inhibition AND ITS TYPES Enzyme inhibition AND ITS TYPES
Enzyme inhibition AND ITS TYPES
Rajpal Choudhary
 

Similar to enzymes lecture 3 2015 animation.pdf (20)

Enzyme inhibition.ppt
Enzyme inhibition.pptEnzyme inhibition.ppt
Enzyme inhibition.ppt
 
Enzyme Inhibitors, Activation energy and MEC.
Enzyme Inhibitors, Activation energy and MEC.Enzyme Inhibitors, Activation energy and MEC.
Enzyme Inhibitors, Activation energy and MEC.
 
Basics of Enzyme Catalysis
Basics of Enzyme CatalysisBasics of Enzyme Catalysis
Basics of Enzyme Catalysis
 
Enzyme inhibition
Enzyme inhibitionEnzyme inhibition
Enzyme inhibition
 
Enz inhi 5 lec
Enz inhi 5 lecEnz inhi 5 lec
Enz inhi 5 lec
 
Enzyme
Enzyme Enzyme
Enzyme
 
Enzyme unit 4 5
Enzyme unit 4  5Enzyme unit 4  5
Enzyme unit 4 5
 
Enzymes
EnzymesEnzymes
Enzymes
 
Enzymology enzyme inhibition &therapeutic uses
Enzymology enzyme inhibition &therapeutic usesEnzymology enzyme inhibition &therapeutic uses
Enzymology enzyme inhibition &therapeutic uses
 
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAYENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
ENZYME INHIBITION MORE INTERESTING IN CHEMISTRY WAY
 
factors affecting enzyme activity
factors affecting enzyme activityfactors affecting enzyme activity
factors affecting enzyme activity
 
enzyme inhibition.pptx
enzyme inhibition.pptxenzyme inhibition.pptx
enzyme inhibition.pptx
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
 
Regulation of enzymes activity 0a08fd94fd.pdf
Regulation of enzymes activity 0a08fd94fd.pdfRegulation of enzymes activity 0a08fd94fd.pdf
Regulation of enzymes activity 0a08fd94fd.pdf
 
Enzymes 2019
Enzymes 2019Enzymes 2019
Enzymes 2019
 
Riversible enzyme inhibitors
Riversible enzyme inhibitorsRiversible enzyme inhibitors
Riversible enzyme inhibitors
 
Enzyme Inhibitors
Enzyme InhibitorsEnzyme Inhibitors
Enzyme Inhibitors
 
Types of enzyme inhibition
Types of enzyme inhibitionTypes of enzyme inhibition
Types of enzyme inhibition
 
Enzyme in-therapy-1-1
Enzyme in-therapy-1-1Enzyme in-therapy-1-1
Enzyme in-therapy-1-1
 
Enzyme inhibition AND ITS TYPES
Enzyme inhibition AND ITS TYPES Enzyme inhibition AND ITS TYPES
Enzyme inhibition AND ITS TYPES
 

More from Annie Annie

Intro. to Food_Sci_1.pptbbbbbiochemistry
Intro. to Food_Sci_1.pptbbbbbiochemistryIntro. to Food_Sci_1.pptbbbbbiochemistry
Intro. to Food_Sci_1.pptbbbbbiochemistry
Annie Annie
 
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptxChemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
Annie Annie
 
CANCER CELL METABOLISM.pptx
CANCER  CELL  METABOLISM.pptxCANCER  CELL  METABOLISM.pptx
CANCER CELL METABOLISM.pptx
Annie Annie
 
Presentation immunology.pptx
Presentation immunology.pptxPresentation immunology.pptx
Presentation immunology.pptx
Annie Annie
 
Proteins
Proteins Proteins
Proteins
Annie Annie
 
AUTOIMMUNITY &IMMUNOTOLERANCE.pptx
AUTOIMMUNITY &IMMUNOTOLERANCE.pptxAUTOIMMUNITY &IMMUNOTOLERANCE.pptx
AUTOIMMUNITY &IMMUNOTOLERANCE.pptx
Annie Annie
 
Interferons, Immunity.pptx
Interferons, Immunity.pptxInterferons, Immunity.pptx
Interferons, Immunity.pptx
Annie Annie
 
immunodeficiency disorders.pptx
immunodeficiency disorders.pptximmunodeficiency disorders.pptx
immunodeficiency disorders.pptx
Annie Annie
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
Annie Annie
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptx
Annie Annie
 
PROPERTIES OF ENZYMES.pptx
PROPERTIES OF ENZYMES.pptxPROPERTIES OF ENZYMES.pptx
PROPERTIES OF ENZYMES.pptx
Annie Annie
 
Regulation of Enzymes.pptx
Regulation of Enzymes.pptxRegulation of Enzymes.pptx
Regulation of Enzymes.pptx
Annie Annie
 
IVF SUCCESS STORY.pptx
IVF SUCCESS STORY.pptxIVF SUCCESS STORY.pptx
IVF SUCCESS STORY.pptx
Annie Annie
 
Endo Prsentation.pptx
Endo Prsentation.pptxEndo Prsentation.pptx
Endo Prsentation.pptx
Annie Annie
 
ORGANIC ACIDEMIAS.pptx
ORGANIC ACIDEMIAS.pptxORGANIC ACIDEMIAS.pptx
ORGANIC ACIDEMIAS.pptx
Annie Annie
 
Utility of enzymes for the production of drugs 1 (1).pptx
Utility of enzymes for the production of drugs 1 (1).pptxUtility of enzymes for the production of drugs 1 (1).pptx
Utility of enzymes for the production of drugs 1 (1).pptx
Annie Annie
 
Lecture 45 2015 Lutz.ppt
Lecture 45 2015 Lutz.pptLecture 45 2015 Lutz.ppt
Lecture 45 2015 Lutz.ppt
Annie Annie
 
MUCLecture_2022_82136961.pptx
MUCLecture_2022_82136961.pptxMUCLecture_2022_82136961.pptx
MUCLecture_2022_82136961.pptx
Annie Annie
 
s15-miller-chap-7b-lecture.ppt
s15-miller-chap-7b-lecture.ppts15-miller-chap-7b-lecture.ppt
s15-miller-chap-7b-lecture.ppt
Annie Annie
 
ELISA & AAS-1.pptx
ELISA & AAS-1.pptxELISA & AAS-1.pptx
ELISA & AAS-1.pptx
Annie Annie
 

More from Annie Annie (20)

Intro. to Food_Sci_1.pptbbbbbiochemistry
Intro. to Food_Sci_1.pptbbbbbiochemistryIntro. to Food_Sci_1.pptbbbbbiochemistry
Intro. to Food_Sci_1.pptbbbbbiochemistry
 
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptxChemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
Chemistry of lipid 3 _lipoprotein chemistry and prostaglandins.pptx
 
CANCER CELL METABOLISM.pptx
CANCER  CELL  METABOLISM.pptxCANCER  CELL  METABOLISM.pptx
CANCER CELL METABOLISM.pptx
 
Presentation immunology.pptx
Presentation immunology.pptxPresentation immunology.pptx
Presentation immunology.pptx
 
Proteins
Proteins Proteins
Proteins
 
AUTOIMMUNITY &IMMUNOTOLERANCE.pptx
AUTOIMMUNITY &IMMUNOTOLERANCE.pptxAUTOIMMUNITY &IMMUNOTOLERANCE.pptx
AUTOIMMUNITY &IMMUNOTOLERANCE.pptx
 
Interferons, Immunity.pptx
Interferons, Immunity.pptxInterferons, Immunity.pptx
Interferons, Immunity.pptx
 
immunodeficiency disorders.pptx
immunodeficiency disorders.pptximmunodeficiency disorders.pptx
immunodeficiency disorders.pptx
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptx
 
PROPERTIES OF ENZYMES.pptx
PROPERTIES OF ENZYMES.pptxPROPERTIES OF ENZYMES.pptx
PROPERTIES OF ENZYMES.pptx
 
Regulation of Enzymes.pptx
Regulation of Enzymes.pptxRegulation of Enzymes.pptx
Regulation of Enzymes.pptx
 
IVF SUCCESS STORY.pptx
IVF SUCCESS STORY.pptxIVF SUCCESS STORY.pptx
IVF SUCCESS STORY.pptx
 
Endo Prsentation.pptx
Endo Prsentation.pptxEndo Prsentation.pptx
Endo Prsentation.pptx
 
ORGANIC ACIDEMIAS.pptx
ORGANIC ACIDEMIAS.pptxORGANIC ACIDEMIAS.pptx
ORGANIC ACIDEMIAS.pptx
 
Utility of enzymes for the production of drugs 1 (1).pptx
Utility of enzymes for the production of drugs 1 (1).pptxUtility of enzymes for the production of drugs 1 (1).pptx
Utility of enzymes for the production of drugs 1 (1).pptx
 
Lecture 45 2015 Lutz.ppt
Lecture 45 2015 Lutz.pptLecture 45 2015 Lutz.ppt
Lecture 45 2015 Lutz.ppt
 
MUCLecture_2022_82136961.pptx
MUCLecture_2022_82136961.pptxMUCLecture_2022_82136961.pptx
MUCLecture_2022_82136961.pptx
 
s15-miller-chap-7b-lecture.ppt
s15-miller-chap-7b-lecture.ppts15-miller-chap-7b-lecture.ppt
s15-miller-chap-7b-lecture.ppt
 
ELISA & AAS-1.pptx
ELISA & AAS-1.pptxELISA & AAS-1.pptx
ELISA & AAS-1.pptx
 

Recently uploaded

Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Wasswaderrick3
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
muralinath2
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
terusbelajar5
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
Abdul Wali Khan University Mardan,kP,Pakistan
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
yqqaatn0
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
HongcNguyn6
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
Bob Reedy - Nitrate in Texas Groundwater.pdf
Bob Reedy - Nitrate in Texas Groundwater.pdfBob Reedy - Nitrate in Texas Groundwater.pdf
Bob Reedy - Nitrate in Texas Groundwater.pdf
Texas Alliance of Groundwater Districts
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
TinyAnderson
 

Recently uploaded (20)

Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
 
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
Bob Reedy - Nitrate in Texas Groundwater.pdf
Bob Reedy - Nitrate in Texas Groundwater.pdfBob Reedy - Nitrate in Texas Groundwater.pdf
Bob Reedy - Nitrate in Texas Groundwater.pdf
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
 

enzymes lecture 3 2015 animation.pdf

  • 1.
  • 4.
  • 6. 6  Enzyme inhibition is one way of regulating enzyme activity .  Most therapeutic drugs function by inhibition of a specific enzyme.  In the body , some of the processes controlled by enzyme inhibition are blood coagulation, blood clot dissolution (fibrinolysis) and inflammatory reactions. Enzyme inhibitors are Reversible or Irreversible
  • 7.  Enzyme Inhibition means decreasing or cessation in the enzyme activity.  The inhibitor is the substance that decreases or abolishes the rate of enzyme action.  According to the similarity between the inhibitor and the substrate, enzyme inhibition is either:  Competitive inhibition:  Non-competitive inhibition: Reversible Irreversible
  • 8. I. Competitive inhibition  There is structural similarity between the inhibitor and substrate.  The inhibitor and the substrate compete with each other to bind to the same catalytic site of the enzyme.  The inhibition is reversible.  It can be relieved by increasing substrate concentration.  It does not affect Vmax. It increases Km.
  • 9. COMPETITIVE INHIBITION 1. Inhibitor compete with substrate 2. Structurally is similar to the substrate 3. Inhibition is reversible 4. Inhibitor does not bind with E-S complex 5. Inhibition is relieved in excess substrate concentration 6. Inhibitor with enzyme forms enzyme inhibitor complex (E-I)
  • 10. Competitive Inhibition presented as: E + S  E●S  E + P + I  E●I I resembles S I binds at active site reversibly E●I cannot bind to S so no reaction substrate inhibitor
  • 11.
  • 12.
  • 13. Molecular interpretation for competitive inhibition competitive inhibitor binds to same site as the substrate (competes). its structure usually resembles substrate. While the inhibitor is bound, the enzyme cannot bind substrate and no reaction possible. Many pharmaceutical agents are competitive inhibitors so are many toxic substances.
  • 14. No I Competitive Inhibition +I +more I Vmax Km In competitive inhibition, can always add enough [S] to overcome inhibition.  same Vmax
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Examples and Clinical Use : 19 1- Malonate blocks the action of Succinate dehydrogenase which catalyzes the transformations of succinate to fumarate
  • 20. The formulae of malonic and succinic acids show the structural similarity between them. COOH COOH CH2 CH2 COOH CH2 COOH Malonic Acid Succinic Acid
  • 21. 21 Succinate and Malonate are 2 structural analogs.
  • 22.
  • 23. 23 2. Sulfonamides : are structural analogs of p-amino benzoic acid used by bacteria for folic acid synthesis. • Folic acid is essential for growth and multiplication . Hence the sulfa drugs as bacteriostatic
  • 24. 24 3. Dicumarol is structurally similar to vitamin K and can act as anticoagulant by competitive inhibition of vitamin K activity
  • 25.
  • 26. Inhibitor Substrate Enzymatic process Malonic acid Succinic acid Succinate dehydrogenase Sulfanilamide Para aminobenzoic acid (PABA) Folic acid synthesis in bacteria Dicumarol Vitamin K Prothrombin synthesis Acetazolamide (diamox) Carbonic acid Carbonic anhydrase Allopurinol (zyloric) Xanthine Xanthine oxidase physostigmine Acetyl choline Choline esterase
  • 27. Enzyme behavior in present of competitive inhibitor:  Vmax is unchanged.  Km is increased, more substrate is needed to keep the reaction going at ½ Vmax.
  • 28. Michaelis Menten hyperbolic plot:  The initial velocity (Vi) of the enzyme reaction rises more slowly when competitive inhibitor is present, but eventually reaches normal Vmax when [S] is very high.
  • 29. No I Competitive Inhibition +I +more I Vmax Km In competitive inhibition, can always add enough [S] to overcome inhibition.  same Vmax
  • 30.
  • 32. Lineweaver-Burk plot:  It shows a steeper slope to the line when a competitive inhibitor is present.  The series of lines pivot on they intercept, since Vmax is not changed for competitive inhibition.  The X-intercept becomes smaller as Km increases in competitive inhibition.
  • 33. 1/[S] 1/v 1/Vmax Competitive inhibition Double reciprocal plot Same 1/v intercept, same Vmax Different slopes, competitive Inhibition changes apparent Km Note: inhibition line always above no inhibition. + more I +I No I
  • 34.
  • 35.
  • 36. Competitive inhibition: Km INCREASED, V-max NO CHANGE
  • 37. AP Biology 2007-2008 Got any Questions?!
  • 38.
  • 39. II- Non-competitive inhibition Non-competitive inhibition may be:  Specific.  Non-specific.
  • 40. Non-specific non-competitive inhibition As enzymes are proteins in nature, any factor that causes protein denaturation will inhibit enzyme activity e.g.  Strong acids,  Strong alkalis,  Severe agitation  Repeated freezing and thawing.
  • 41. Specific non-competitive inhibition  There is no structural similarity between the inhibitor and the substrate.  The inhibitor does not bind to the catalytic site as the substrate but it binds to another site.  It can bind enzyme or to enzyme substrate complex.  The inhibition is irreversible. It cannot be relieved by increasing substrate concentration.  It decreases Vmax. It does not affect Km.
  • 42. NON-COMPETITIVE INHIBITION Not resemble substrate Binds to site other than active site Can bind with ES complex Usually It is irreversible Increasing substrate concentration not abolish inhibition
  • 44. Noncompetitive Inhibition E + S  E●S E + P + + I I   E●I  E●S●l inhibitor substrate E●I and E●S●I not productive, depletes E and E●S
  • 45.
  • 46.
  • 47.
  • 48. Non- Competitive Inhibition 48  [I] and [S] may combine at different sites of the enzyme, so formation of both [El] and [EIS] complexes is possible.  Since [EIS] may break down to form product at a slower rate than [ES] complex, the reaction may be slowed but not stopped. Irreversible non competitive inhibition decreases Vmax but does not affect Km.
  • 49. Noncompetitive Inhibition E + S  E●S E + P + + I I   E●I  E●S●l inhibitor substrate E●I and E●S●I not productive, depletes E and E●S
  • 50. Molecular Interpretation: Inhibitor binds the enzyme somewhere different from where the substrate binds. So the inhibitor does not care whether substrate is bound or not. Inhibitor changes the conformation of the enzyme at the active site so no reaction is possible with inhibitor bound. E●I and E●S●I not productive
  • 51.
  • 52.
  • 53. Non-competitive inhibition may be caused by:  Inhibition of sulphahydryl group.  Inhibition of cofactors.  Inhibition of specific ion activator.
  • 54. A) Inhibition of Sulphahydryl (-SH) group  Many enzymes depend on free sulphahydryl group for its activity.  Inhibition of this group leads to loss of the enzyme activity.
  • 55. Sulphahydryl group can be inhibited by: 1- Oxidizing agents as potassiumferricyanide 2 E-SH E-S-S-E Potassium Ferricyanide Potassium Ferrocyanide Where E-SH is an enzyme containing free sulphahydryl group.
  • 56. 2- Alkylating agents as iodoacetic acid (I-CH2- COOH) and iodoacetamide E-SH E-S-CH2-COOH I-CH2-COOH HI (iodic acid)
  • 57. 3- Effect of heavy metals: Heavy metal ions as mercury (Hg++) and lead (Pb++) block sulphahydryl group of enzymes forming mercaptides. 2 E-SH + Pb++ E-S-Pb-E-S
  • 58. B) Inhibition of cofactors The inhibitors block an active group in coenzymes or the prosthetic group:
  • 59. 1- Coenzyme inhibition: e.g. hydrazine and hydroxylamine block the aldehyde group in the pyridoxal phosphate, which is a coenzyme needed for transmination, decarboxylation and desulfhydration of amino acids.
  • 60. 2- Inhibitors of prosthetic group: e.g. carbon monoxide (CO), cyanide and bisulphate block the iron in the haem which is the prosthetic group of cytochrome oxidase enzyme.
  • 61. C) Inhibition of metal ion activator  Removal of calcium ions from blood prevents its coagulation.  Ca++ is needed to activate thrombokinase enzyme which converts the inactivate prothrombin to active thrombin that causes blood clotting.
  • 62. Enzyme behavior in presence of non-competitive inhibitor:  Vmax is decreased.  Km remains unchanged.
  • 63. Michaelis Menten hyperbolic plot:  It shows that the initial velocity (Vi) of the enzyme reaction rises more slowly when non- competitive inhibitor is present, and levels off at reduced Vmax.
  • 64.
  • 66. Lineweaver-Burk plot:  It shows that the series of lines pivot on the negative X intercept, since Km is unchanged for non-competitive inhibition.  Y-intercept and slope increase due to the reciprocal dependence on Vmax, which decreases.
  • 67. No I + I 1/[S] 1/v Noncompetitive Inhibition different slopes, different 1/v intercepts.
  • 68.
  • 69.
  • 70. Non competitive inhibition : Km no change , V-max decreased
  • 71.
  • 72.
  • 73. AP Biology 2007-2008 Got any Questions?!
  • 74. The Effects of Inhibitors on Enzyme Kinetics The distinction between competitive and non- competitive enzyme inhibition can be determined by plotting enzyme activity with and without the inhibitor present.
  • 75. Enzyme behavior in present of competitive inhibitor:  Vmax is unchanged.  Km is increased, more substrate is needed to keep the reaction going at ½ Vmax.
  • 77.
  • 78. Enzyme behavior in presence of non-competitive inhibitor:  Vmax is decreased.  Km remains unchanged.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84. AP Biology 2007-2008 Don’t be inhibited! Ask Questions!
  • 85. Activity  1- …………… occurs when the inhibitory chemical, which has no similarity to the substrate, binds to the enzyme other than at the active site. (A) Noncompetitive Inhibition (B) Competitive Inhibition (C) Un-catalysed reaction (D) All A, B and C  2- Km values are not altered by which type of inhibitor a) Competitive inhibitors b) Non competitive inhibitors c) Uncompetitive inhibitors d) All of these
  • 86. Activity  1- The inhibition of succinate dehydrogenase by malonate is an example for (A) Noncompetitive Inhibition (B) Competitive Inhibition (C) Feed back inhibition (D) None of these 2- The noncompetitive inhibitor a) Increases Vmax and Km b) Decreases Vmax c) Increases Km without affecting Vmax d) Decreases Km and Vmax
  • 87. Activity  Compare between competitive and non competitive enzyme inhibition.  Discuss with 3 examples competitive inhibition  Enumerate 3 methods of noncompetitive inhibition  Discuss in short the effect of inhibitors on enzyme kinetics .
  • 88.